Gland Pharma (NSE:GLAND) Inventory Turnover: 0.34 (As of Mar. 2026)

What is Gland Pharma Inventory Turnover?

Gland Pharma NSE:GLAND +0.66% 83 Inventory Turnover is 0.34 as of Mar. 2026. GuruFocus rates NSE:GLAND with a GF Score™ of 83/100 and a GF Value™ of ₹2,132.00 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Gland Pharma's Cost of Goods Sold for the three months ended in Mar. 2026 was ₹5,913 Mil. Gland Pharma's Average Total Inventories for the quarter that ended in Mar. 2026 was ₹17,439 Mil. Gland Pharma's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.34.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Gland Pharma's Days Inventory for the three months ended in Mar. 2026 was 269.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Gland Pharma's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.00.

Gland Pharma (NSE:GLAND) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gland Pharma's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	17438.89	/	5913.31	*	365 / 4
	=	269.10

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gland Pharma's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	17438.89	/	17427.9
	=	1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Gland Pharma Inventory Turnover Related Terms

Gland Pharma Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Gland Pharma's Inventory Turnover can be seen below:

Gland Pharma Inventory Turnover Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Inventory Turnover

Get a 7-Day Free Trial

1.71

1.08

1.21

1.25

1.31

Gland Pharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.29	0.31	0.31	0.32	0.34

83GF Score

Gland Pharma Ltd NSE:GLAND

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Gland Pharma Inventory Turnover Calculation

Gland Pharma's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

	Inventory Turnover (A: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2026 )	/ (	(Total Inventories (A: Mar. 2025 )	+	Total Inventories (A: Mar. 2026 ))	/	count )
=	22429.3	/ (	(16852.18	+	17438.89)	/	2 )
=	22429.3	/	17145.535
=	1.31

Gland Pharma's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	5913.31	/ (	(0	+	17438.89)	/	1 )
=	5913.31	/	17438.89
=	0.34

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.34 mean?

Gland Pharma (NSE:GLAND) has a Inventory Turnover of 0.34 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Gland Pharma and its competitors.

Is Gland Pharma's Inventory Turnover too high?

Gland Pharma's current Inventory Turnover is 0.34. Overall, Gland Pharma has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Gland Pharma's Inventory Turnover compare to ZTS and UTHR?

Gland Pharma's Inventory Turnover of 0.34 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Gland Pharma and its competitors. Gland Pharma's current Inventory Turnover is 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Gland Pharma stock overvalued right now?

Based on GuruFocus' analysis, Gland Pharma (NSE:GLAND) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,132.00, compared to a current price of ₹2,462.30 — trading 15.5% above its estimated fair value. The current Inventory Turnover is 0.34. Gland Pharma's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Gland Pharma (NSE:GLAND), the current Inventory Turnover is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gland Pharma (NSE:GLAND) Overvalued in 2026?

Based on GuruFocus' analysis, Gland Pharma stock appears to be overvalued. The current stock price of ₹2,462.30 is trading 15.5% above its estimated GF Value™ of ₹2,132.00. GuruFocus considers Gland Pharma to be Modestly Overvalued.

Key valuation signals for NSE:GLAND:

Inventory Turnover: 0.34
GF Value™: ₹2,132.00 vs. price of ₹2,462.30 (15.5% above fair value)
GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the NSE:GLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gland Pharma Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BOM:532331 BOM:506943 BOM:544210 BOM:524494 BOM:532300 BOM:524558 BOM:543635 BOM:500488 BOM:506820 BOM:540596 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 543245:India

Address TSIIC, Phase - IV, Plot No. 11 and 84, Pashamylaram (V), Patancheru M, Sangareddy District, Hyderabad, TG, IND, 502307

Website https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, and Daptomycin Injection, among others. The group is also involved in a vast range of therapeutic categories, including Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarials, Cardiology, and more, to Hormones and related Drugs, Fertility Supplements, and GnRH Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA, and the rest from Europe, India, Canada, Australia, and other regions.

83GF Score

Get the complete analysis for NSE:GLAND

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,462.30

Price

₹2,132.00

GF Value

View NSE:GLAND Analysis

See Inventory Turnover data for all stocks →